Neurofilament light: a potential non-invasive biomarker for neurodegeneration in Alzheimer’s disease

Takeaway

  • Plasma neurofilament light (NfL) is a good candidate for a non-invasive biomarker for neurodegeneration in mild cognitive impairment (MCI) and Alzheimer’s disease (AD).

Why this matters

    Identification of a non-invasive biomarker for neurodegeneration would likely help monitor drug effects in trials.